手法を比較
選択した手法を並べて確認できます。異なる行はハイライト表示されます。
| Health Economicsにおける意思決定分析モデリング× | Quality-Adjusted Life Year (QALY)× | |
|---|---|---|
| 分野 | 医療経済学 | 医療経済学 |
| 系統 | Process / pipeline | Process / pipeline |
| 提唱年≠ | 1975 | 1985 |
| 提唱者≠ | Pauker & Kassirer (medical decision analysis, Massachusetts General Hospital) | Alan Williams (Health Economics Research Centre, Oxford University) |
| 種類 | Method | Method |
| 原典≠ | Pauker, S. G., & Kassirer, J. P. (1975). Therapeutic Decision Making: A Cost-Benefit Analysis. New England Journal of Medicine, 293(5), 229-234. DOI ↗ | Kind, P. (1989). The EuroQol instrument: an index of health-related quality of life. In B. Teeling Smith (Ed.), Measuring health: a practical approach. Chichester: Wiley. link ↗ |
| 別名≠ | decision analysis, decision tree, decision model, health economic model | QALY, health utility measure |
| 関連 | 5 | 5 |
| 概要≠ | Decision analytic modeling is a systematic framework for comparing health interventions by integrating evidence on probabilities, outcomes, costs, and patient preferences into a quantitative model. Developed by Pauker and Kassirer in 1975, decision analysis structures clinical uncertainty and economic trade-offs, enabling transparent comparison of treatment options and identification of optimal strategies. Used in health technology assessment, clinical practice guideline development, and resource allocation decisions. | A QALY measures health benefit as utility weight (0 = death, 1 = perfect health) multiplied by time lived. Developed by Alan Williams in 1985, QALYs enable comparison of disparate health interventions on a common metric. Used globally by health technology assessment bodies—NICE (UK), HAS (France), CADTH (Canada), WHO—to decide which treatments deserve public funding. |
| ScholarGateデータセット ↗ |
|
|